Xinxin Wang

机构：First Hospital of China Medical University, Zhejiang University of Technology, China Medical University · ORCID：0000-0002-1986-0217

发表论文 47 篇 · 总被引 609 次 · h-index 14

代表论文

• PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells (2021 · Molecular Therapy · 被引 84)
• Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response (2021 · Advanced Science · 被引 54)
• CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies (2023 · Leukemia · 被引 40)
• Exploiting T cell signaling to optimize engineered T cell therapies (2021 · Trends in cancer · 被引 36)
• Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL) (2020 · Cancer Research · 被引 30)
• Prognostic factors of pancreatic tumors in children and adolescents: a population study based on the surveillance, epidemiology, and end results database (2024 · BMC Gastroenterology · 被引 14)